LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-09-21
Case ID: NM_058216.3_c.571_15G_T_20260921_230953
Framework: ACMG/AMP 2015
Variant classification summary

NM_058216.3:c.571+15G>T

RAD51C  · NP_478123.1:p.?  · NM_058216.3
GRCh37: chr17:56774235 G>T  ·  GRCh38: chr17:58696874 G>T
Gene: RAD51C Transcript: NM_058216.3
Final call
VUS
PM2 supporting BP4 supporting
All criteria require review: For research and educational purposes only.
Gene
RAD51C
Transcript
NM_058216.3
Protein
NP_478123.1:p.?
gnomAD AF
1.611725426456349e-05 (v4.1)
ClinVar
Likely benign
OncoKB
Interpretation summary
Generated evidence synthesis
1
PM2 (supporting, pathogenic direction): gnomAD v4.1 allele frequency 0.0000161 (26/1,613,178; grpmax FAF 0.0000138) sits below the 0.0001 rarity threshold.
2
BP4 (supporting, benign direction): SpliceAI max delta 0.006 predicts no impact on splicing in this intronic variant.
3
Not applied: PVS1 not applicable (non-canonical intronic change, no null-variant class, no splice effect), BA1/BS1/BS2 not met (frequency far below thresholds), PP5/BP6 not met (no expert-panel assertion), PM1/PM3/PM4/PM5/PP2/BP1/BP2/BP3/BP7 not met or not applicable.
Final determination: Under the generic ACMG/AMP 2015 combination rules no pathogenic combination is reached (no PVS1, PS or >=2 PM criteria; only one supporting-level PM2) and no benign or likely-benign combination is reached (no BA1, no BS criterion, and a single supporting BP4 does not satisfy the 2-BP rule), so the one pathogenic-direction and one benign-direction supporting criteria conflict and the variant is classified Variant of Uncertain Significance.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: c.571+15G>T is a deep intronic non-canonical variant (SpliceAI max delta 0.006), not a null variant, and no RNA evidence exists.
cspec spliceai pvs1_generic_framework PMID:25741868
PS1 N/A Not applicable: c.571+15G>T is intronic with predicted consequence p.?, so it produces no amino-acid change to match against an established pathogenic variant.
cspec PMID:25741868 PMID:25394175
PS2 Not assessed Not assessed: no proband and no parental/trio testing data exist in this case, so a confirmed de novo occurrence cannot be evaluated.
cspec PMID:25741868 clinvar
PS3 Not assessed Not assessed: no RNA or protein functional assay has been reported for RAD51C c.571+15G>T, so PS3 has no assay evidence.
PMID:25741868 cspec clinvar
PS4 Not assessed Not assessed: no case-control data or affected probands exist for c.571+15G>T, so no enrichment statistic could be compared.
clinvar cspec PMID:20301575 PMID:25394175 PMID:25741868 PMID:28492532
PM1 Not met Not met: c.571+15G>T is intronic (intron 3, p.?) with no residue inside any RAD51C critical domain or hotspot, and no VCEP domain table exists for this gene.
cspec final_classification_framework spliceai clinvar PMID:25741868
PM2 Met Met (supporting): gnomAD v4.1 total allele frequency 0.0000161 (26/1,613,178; grpmax FAF 0.0000138) is below the 0.0001 PM2 threshold.
gnomad_v2 gnomad_v4 cspec PMID:25741868
PM3 Not met Not met: no trans-with-pathogenic RAD51C observation exists; all four ClinVar submitters report likely benign without any phasing evidence for this intronic variant.
cspec clinvar PMID:25741868
PM4 N/A Not applicable: c.571+15G>T is intronic with no protein-length change (p.?), so the PM4 in-frame indel/stop-loss requirement is not met.
cspec spliceai PMID:25741868
PM5 N/A Not applicable: c.571+15G>T alters no codon (p.?), so there is no residue at which a different pathogenic missense could be compared.
pm5_candidates cspec PMID:25741868
PM6 Not assessed Not assessed: no proband and no parental genotypes of any kind were reported, so no assumed de novo event could be evaluated.
cspec PMID:25741868 clinvar
PP1 Not assessed Not assessed: zero family members or informative meioses are documented, so co-segregation with disease cannot be observed.
cspec PMID:25741868 clinvar
PP2 N/A Not applicable: PP2 is restricted to missense variants, and c.571+15G>T is intronic with no amino-acid substitution (p.?).
cspec PMID:25741868
PP3 Not met Not met: SpliceAI max delta 0.006 falls far below the >=0.2 supporting PP3 threshold.
spliceai cspec
PP4 Not assessed Not assessed: no proband phenotype or family history is available to test specificity for RAD51C.
clinvar cspec PMID:25741868
PP5 Not met Not met: the exact-variant ClinVar record has four non-expert laboratory submissions and zero expert-panel assertions.
clinvar cspec PMID:25741868
BA1 Not met Not met: the highest observed allele frequency, 0.00018 in a small 'Remaining individuals' bin, is far below the 0.05 BA1 stand-alone threshold.
gnomad_v2 gnomad_v4 cspec PMID:25741868
BS1 Not met Not met: dataset allele frequencies of 0.0000161 (gnomAD v4.1) and 0.0000203 (v3.1 non-cancer genomes) are far below the 0.01 BS1 threshold.
gnomad_v2 gnomad_v4 cspec
BS2 Not met Not met: only one homozygous adult is reported (gnomAD v4.1, 26/1,613,178 alleles) and RAD51C cancer risk is adult-onset with reduced penetrance, failing BS2's healthy-adult requirement.
gnomad_v2 gnomad_v4 PMID:25741868
BS3 Not assessed Not assessed: no functional assay shows normal splicing or preserved RAD51C function for c.571+15G>T, so BS3 lacks its required supporting evidence.
PMID:25741868 cspec clinvar
BS4 Not assessed Not assessed: no pedigree or relative genotypes exist, so non-segregation in a family cannot be demonstrated by any source.
cspec PMID:25741868 clinvar
BP1 N/A Not applicable: BP1 is limited to missense variants, and c.571+15G>T is intronic with no amino-acid substitution (p.?).
pvs1_gene_context cspec PMID:25741868
BP2 Not met Not met: no cis/trans phase relationship with a pathogenic RAD51C variant exists; gnomAD v4.1's lone homozygote (26/1,613,178 alleles) is not trans-with-pathogenic evidence.
cspec clinvar gnomad_v2 gnomad_v4 PMID:25741868
BP3 N/A Not applicable: c.571+15G>T is a single-nucleotide intronic substitution (p.?), not an in-frame indel in a repeat region as BP3 requires.
cspec PMID:25741868
BP4 Met Met (supporting): SpliceAI max delta 0.006 is below the <=0.1 BP4 supporting threshold.
spliceai cspec
BP5 Not assessed Not assessed: no proband or case-level data exist to show an alternate molecular basis for disease.
clinvar cspec PMID:25741868
BP6 Not met Not met: ClinVar reports Likely benign from four non-expert laboratories, with no expert-panel assertion to trigger BP6.
clinvar cspec PMID:25741868
BP7 N/A Not applicable: c.571+15G>T is intronic, not a synonymous variant, so BP7's scope is not met.
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.